|
|
- 2017
An amylin analog used as a challenge test for Alzheimer's diseaseDOI: 10.1016/j.trci.2016.12.002 Keywords: Alzheimer's disease (AD), Amylin challenge, Pramlintide, Safety, Diagnosis, Biomarkers Abstract: Preclinical studies demonstrate the potential of amylin in the diagnosis of Alzheimer's disease (AD). We aimed to lay the foundation for repurposing the amylin analog and a diabetes drug, pramlintide, for AD in humans
|
